August Issue of AABB News Focuses on the Future of Biotherapies

The August issue of AABB News examines the expanding role of cell and gene therapies and the challenges of bringing these treatments to more patients.

The cover story explores how collaboration among key stakeholders can help reduce logistical barriers to CAR T-cell therapy. The issue also profiles 2026 Emily Cooley Memorial Award recipient Don Siegel, PhD, MD, highlighting his contributions to antibody engineering and cellular therapies and his decades of mentorship in transfusion medicine and biotherapies.

Also in this issue, readers can preview Transfusion’s inaugural biotherapies-focused supplement, which features 12 peer-reviewed articles examining the evolving roles of transfusion medicine, cellular starting material, cord blood, immune effector cell therapies and other areas.

Additional coverage explores the ethical challenges of geographic access to advanced therapies, AABB accreditation for prehospital transfusion programs, and developments in biotherapies and transfusion medicine around the world.